Frontiers of Medicine

, Volume 8, Issue 2, pp 254–258

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Authors

  • Muhammad Furqan
    • Division of Hematology and Oncology, Department of MedicineWestchester Medical Center
  • Yamei Chen
    • Division of Hematology and Oncology, Department of MedicineWestchester Medical Center
    • Department of Hematology, Xiamen Zhongshan HospitalXiamen University
  • Akintunde Akinleye
    • Division of Hematology and Oncology, Department of MedicineWestchester Medical Center
  • Judy Sarungbam
    • Department of PathologyWestchester Medical Center
  • Alan Gass
    • Division of Cardiology, Department of MedicineWestchester Medical Center
  • Karen Seiter
    • Division of Hematology and Oncology, Department of MedicineWestchester Medical Center
    • Division of Hematology and Oncology, Department of MedicineWestchester Medical Center
Case Report

DOI: 10.1007/s11684-014-0319-1

Cite this article as:
Furqan, M., Chen, Y., Akinleye, A. et al. Front. Med. (2014) 8: 254. doi:10.1007/s11684-014-0319-1
  • 62 Views

Abstract

Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term “mantle cell lymphoma” in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

Keywords

mantle cell lymphomabendamustinecardiogenic shock

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2014